2016 Grant Recipients

2016 was the second round of grant funding awarded by Avner's Foundation and brings the total grant funding to date to $3.9 million. Our esteemed Scientific Advisory Panel of international and national experts assessed the applications and made their recommendations to the board of Avner’s Foundation, these were unanimously accepted.

Accelerator Grants

A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis
The Australian Pancreatic Cancer Organoid Biobank

Innovation Grants

Therapeutically targeting a solute carrier transporter in the stroma of pancreatic cancer
Development of Novel Agents that Target P-Glycoprotein Resistant Pancreatic Cancer
A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis
Utilising a novel predictor to stratify patients with therapy-resistant pancreatic cancer for treatment with CHK inhibitor drugs to improve responses and outcomes